CoChat

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination

Jacob, Christopher G, Thuy-Nhien, Nguyen, Mayxay, Mayfong, Maude, Richard J, Quang, Huynh Hong, Hongvanthong, Bouasy, Vanisaveth, Viengxay, Ngo Duc, Thang, Rekol, Huy, van der Pluijm, Rob, von Seidlein, Lorenz, Fairhurst, Rick, Nosten, François, Hossain, Md Amir, Park, Naomi, Goodwin, Scott, Ringwald, Pascal, Chindavongsa, Keobouphaphone, Newton, Paul, Ashley, Elizabeth, Phalivong, Sonexay, Maude, Rapeephan, Leang, Rithea, Huch, Cheah, Dong, Le Thanh, Nguyen, Kim-Tuyen, Nhat, Tran Minh, Hien, Tran Tinh, Nguyen, Hoa, Zdrojewski, Nicole, Canavati, Sara, Sayeed, Abdullah Abu, Uddin, Didar, Buckee, Caroline, Fanello, Caterina I, Onyamboko, Marie, Peto, Thomas, Tripura, Rupam, Amaratunga, Chanaki, Myint Thu, Aung, Delmas, Gilles, Landier, Jordi, Parker, Daniel M, Chau, Nguyen Hoang, Lek, Dysoley, Suon, Seila, Callery, James, Jittamala, Podjanee, Hanboonkunupakarn, Borimas, Pukrittayakamee, Sasithon, Phyo, Aung Pyae, Smithuis, Frank, Lin, Khin, Thant, Myo, Hlaing, Tin Maung, Satpathi, Parthasarathi, Satpathi, Sanghamitra, Behera, Prativa K, Tripura, Amar, Baidya, Subrata, Valecha, Neena, Anvikar, Anupkumar R, Ul Islam, Akhter, Faiz, Abul, Kunasol, Chanon, Drury, Eleanor, Kekre, Mihir, Ali, Mozam, Love, Katie, Rajatileka, Shavanthi, Jeffreys, Anna E, Rowlands, Kate, Hubbart, Christina S, Dhorda, Mehul, Vongpromek, Ranitha, Kotanan, Namfon, Wongnak, Phrutsamon, Almagro Garcia, Jacob, Pearson, Richard D, Ariani, Cristina V, Chookajorn, Thanat, Malangone, Cinzia, Nguyen, T, Stalker, Jim, Jeffery, Ben, Keatley, Jonathan, Johnson, Kimberly J, Muddyman, Dawn, Chan, Xin Hui S, Sillitoe, John, Amato, Roberto, Simpson, Victoria, Gonçalves, Sonia, Rockett, Kirk, Day, Nicholas P, Dondorp, Arjen M, Kwiatkowski, Dominic P, Miotto, Olivo · 2021 · eLife

Published version of a preprint

Cited by 110

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community. Funding: The GenRe-Mekong project is funded by the Bill and Melinda Gates Foundation (OPP11188166, OPP1204268). Genotyping and sequencing were funded by the Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z) and Medical Research Council (G0600718). A proportion of samples were collected with the support of the UK Department for International Development (201900, M006212), and Intramural Research Program of the National Institute of Allergy and Infectious Diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.62997

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 39

  1. Agrawal, 2017, Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity, The Journal of Infectious Diseases, 216, 468, 10.1093/infdis/jix334 · DOI
  2. Amaratunga, 2016, Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, The Lancet Infectious Diseases, 16, 357, 10.1016/S1473-3099(15)00487-9 · DOI · Paper page
  3. Amato, 2017, Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, The Lancet Infectious Diseases, 17, 164, 10.1016/S1473-3099(16)30409-1 · DOI · Paper page
  4. Amato, 2018, Origins of the current outbreak of multidrug-resistant malaria in Southeast Asia: a retrospective genetic study, The Lancet Infectious Diseases, 18, 337, 10.1016/S1473-3099(18)30068-9 · DOI · Paper page
  5. Ariey, 2014, A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, 505, 50, 10.1038/nature12876 · DOI · Paper page
  6. Artimovich, 2015, Persistence of Sulfadoxine-Pyrimethamine resistance despite reduction of drug pressure in Malawi, Journal of Infectious Diseases, 212, 694, 10.1093/infdis/jiv078 · DOI
  7. Chang, 2019, Mapping imported malaria in Bangladesh using parasite genetic and human mobility data, eLife, 8, 10.7554/eLife.43481 · DOI · Paper page
  8. Chaumeau, 2018, Entomological determinants of malaria transmission in Kayin state, Eastern Myanmar: A 24-month longitudinal study in four villages, Wellcome Open Research, 3, 10.12688/wellcomeopenres.14761.1 · DOI
  9. Daniels, 2015, Modeling malaria genomics reveals transmission decline and rebound in Senegal, PNAS, 112, 7067, 10.1073/pnas.1505691112 · DOI · Paper page
  10. Desmond-Hellmann, 2016, Progress lies in precision, Science, 353, 10.1126/science.aai7598 · DOI
  11. Directorate of National Vector Borne Disease Control Programme DGoHS, Government of India. 2013. Ministry of Health and Family Welfare. National Drug Policy on Malaria.
  12. Escalante, 2009, The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum, Trends in Parasitology, 25, 557, 10.1016/j.pt.2009.09.008 · DOI
  13. Felger, 2020, PCR correction strategies for malaria drug trials: updates and clarifications, The Lancet Infectious Diseases, 20, e20, 10.1016/S1473-3099(19)30426-8 · doi:10.1016/s1473-3099(19)30426-8
  14. Frosch, 2014, Return of widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi, The Journal of Infectious Diseases, 210, 1110, 10.1093/infdis/jiu216 · doi:10.1093/infdis/jiu216
  15. Hamilton, 2019, Evolution and expansion of multidrug-resistant malaria in Southeast Asia: a genomic epidemiology study, The Lancet Infectious Diseases, 19, 943, 10.1016/S1473-3099(19)30392-5 · DOI · Paper page
  16. Landier, 2018, Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme, The Lancet, 391, 1916, 10.1016/S0140-6736(18)30792-X · DOI · Paper page
  17. Laufer, 2006, Return of chloroquine antimalarial efficacy in Malawi, New England Journal of Medicine, 355, 1959, 10.1056/NEJMoa062032 · DOI · Paper page
  18. Leang, 2015, Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine Open-Label multicenter clinical assessment, Antimicrobial Agents and Chemotherapy, 59, 4719, 10.1128/AAC.00835-15 · DOI · Paper page
  19. Lim, 2013, Ex vivo Susceptibility of Plasmodium falciparum to Antimalarial Drugs in Western, Northern, and Eastern Cambodia, 2011-2012: Association with Molecular Markers, Antimicrobial Agents and Chemotherapy, 57, 5277, 10.1128/AAC.00687-13 · DOI
  20. MalariaGEN Plasmodium falciparum Community Project, 2016, Genomic epidemiology of artemisinin resistant malaria, eLife, 5, 10.7554/eLife.08714 · DOI · Paper page
  21. Ménard, 2016, A worldwide map of Plasmodium falciparum K13-Propeller Polymorphisms, New England Journal of Medicine, 374, 2453, 10.1056/NEJMoa1513137 · DOI · Paper page
  22. Miotto, 2013, Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia, Nature Genetics, 45, 648, 10.1038/ng.2624 · DOI · Paper page
  23. Miotto, 2015, Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nature Genetics, 47, 226, 10.1038/ng.3189 · DOI · Paper page
  24. Mita, 2009, Spread and evolution of Plasmodium falciparum drug resistance, Parasitology International, 58, 201, 10.1016/j.parint.2009.04.004 · DOI · Paper page
  25. Mita, 2011, Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations, The Journal of Infectious Diseases, 204, 1980, 10.1093/infdis/jir664 · DOI
  26. Nagar, 2019, Population pharmacogenomics for precision public health in Colombia, Frontiers in Genetics, 10, 10.3389/fgene.2019.00241 · DOI
  27. Noedl, 2008, Evidence of Artemisinin-Resistant malaria in western Cambodia, New England Journal of Medicine, 359, 2619, 10.1056/NEJMc0805011 · DOI · Paper page
  28. Oyola, 2016, Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification, Malaria Journal, 15, 10.1186/s12936-016-1641-7 · doi:10.1186/s12936-016-1641-7
  29. Pearson, 2019, An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples, 10.1101/824730 · DOI
  30. Plowe, 2009, The evolution of drug-resistant malaria, Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, S11, 10.1016/j.trstmh.2008.11.002 · DOI
  31. Roper, 2004, Intercontinental spread of pyrimethamine-resistant malaria, Science, 305, 10.1126/science.1098876 · DOI · Paper page
  32. Ross, 2018, Emerging southeast asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine, Nature Communications, 9, 10.1038/s41467-018-05652-0 · DOI · Paper page
  33. Spring, 2015, Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, The Lancet Infectious Diseases, 15, 683, 10.1016/S1473-3099(15)70049-6 · DOI · Paper page
  34. Takala-Harrison, 2015, Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, The Journal of Infectious Diseases, 211, 670, 10.1093/infdis/jiu491 · DOI · Paper page
  35. Trape, 1998, Impact of chloroquine resistance on malaria mortality, Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie, 321, 689, 10.1016/S0764-4469(98)80009-7 · DOI · Paper page
  36. van der Pluijm, 2019, Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study, The Lancet Infectious Diseases, 19, 952, 10.1016/S1473-3099(19)30391-3 · DOI · Paper page
  37. von Seidlein, 2019, The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial, PLOS Medicine, 16, 10.1371/journal.pmed.1002745 · DOI · Paper page
  38. World Health Organization, 2017, Update on Artemisinin Resistance
  39. World Health Organization. 2018. Geneva: World Health Organization. Status Report on Artemisinin Resistance and ACT Efficacy.

Cited by

See all 110

Metadata

Authors
Jacob, C. G., Thuy-Nhien, N., Mayxay, M., Maude, R. J., Quang, H. H., Hongvanthong, B., Vanisaveth, V., Ngo Duc, T., Rekol, H., van der Pluijm, R., von Seidlein, L., Fairhurst, R., Nosten, F., Hossain, M. A., Park, N., Goodwin, S., Ringwald, P., Chindavongsa, K., Newton, P., Ashley, E., Phalivong, S., Maude, R., Leang, R., Huch, C., Dong, L. T., Nguyen, K.-T., Nhat, T. M., Hien, T. T., Nguyen, H., Zdrojewski, N., Canavati, S., Sayeed, A. A., Uddin, D., Buckee, C., Fanello, C. I., Onyamboko, M., Peto, T., Tripura, R., Amaratunga, C., Myint Thu, A., Delmas, G., Landier, J., Parker, D. M., Chau, N. H., Lek, D., Suon, S., Callery, J., Jittamala, P., Hanboonkunupakarn, B., Pukrittayakamee, S., Phyo, A. P., Smithuis, F., Lin, K., Thant, M., Hlaing, T. M., Satpathi, P., Satpathi, S., Behera, P. K., Tripura, A., Baidya, S., Valecha, N., Anvikar, A. R., Ul Islam, A., Faiz, A., Kunasol, C., Drury, E., Kekre, M., Ali, M., Love, K., Rajatileka, S., Jeffreys, A. E., Rowlands, K., Hubbart, C. S., Dhorda, M., Vongpromek, R., Kotanan, N., Wongnak, P., Almagro Garcia, J., Pearson, R. D., Ariani, C. V., Chookajorn, T., Malangone, C., Nguyen, T., Stalker, J., Jeffery, B., Keatley, J., Johnson, K. J., Muddyman, D., Chan, X. H. S., Sillitoe, J., Amato, R., Simpson, V., Gonçalves, S., Rockett, K., Day, N. P., Dondorp, A. M., Kwiatkowski, D. P., & Miotto, O.
Venue
eLife
Published
2021-08-10
Volume
10
ISSN
2050-084X
Cited by
110
References
4
Language
en
Funders
  • Bill and Melinda Gates Foundation (OPP11188166, OPP1204268)
  • Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z)
  • Medical Research Council (G0600718)
  • Department for International Development, UK Government (201900, M006212)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. https://app.cochat.ai/papers/10.7554/elife.62997
The paper
Jacob, C. G., Thuy-Nhien, N., Mayxay, M., Maude, R. J., Quang, H. H., Hongvanthong, B., Vanisaveth, V., Ngo Duc, T., Rekol, H., van der Pluijm, R., von Seidlein, L., Fairhurst, R., Nosten, F., Hossain, M. A., Park, N., Goodwin, S., Ringwald, P., Chindavongsa, K., Newton, P., . . . Miotto, O. (2021). Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. eLife. https://doi.org/10.7554/elife.62997

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.